Please login to the form below

Not currently logged in
Email:
Password:

European Union

This page shows the latest European Union news and features for those working in and with pharma, biotech and healthcare.

Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges

Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges

With a total budget of 2.4bn, the IHI is a public-private partnership between the European Union (EU) and Europe’s life sciences industries aiming to translate health research and

Latest news

More from news
Approximately 10 fully matching, plus 333 partially matching documents found.

Latest Intelligence

  • A creative awakening – how pharma is bringing innovation to the patient journey A creative awakening – how pharma is bringing innovation to the patient journey

    Precipice of change. The European Institute of Innovation and Technology (EIT), a not-for-profit catalyst co- funded by the European Union, believes that bringing people together is a key component

  • EU cross-border healthcare EU cross-border healthcare

    Furthermore, the disease expertise and specialist skills that are required may not be widely available in every European country. ... There’s a real opportunity for the European Union to act as a ‘one-stop shop’ to increase process transparency and

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    This was the first trade deal reached by the United Kingdom following its departure from the European Union. ... Perhaps unsurprisingly, London is the most popular European city for Japanese residents to live in overseas and therefore gives a clear

  • An EU emergency health fund to limit the impact of future crises An EU emergency health fund to limit the impact of future crises

    risks. The ongoing and unprecedented public health crisis caused by COVID-19 has overstretched the structures and mechanisms of the European Union, especially those that deal with emergencies. ... Due to its financial innovation, not only does it

  • Biopharma and orphan drugs Biopharma and orphan drugs

    In the European Union, the Orphan Drug Regulation was adopted in 2000. ... Support success. According to Lavinia Meloni, spokeswoman for the European Federation of Pharmaceutical Industries and Associations, efforts to encourage development of drugs for

More from intelligence
Approximately 1 fully matching, plus 47 partially matching documents found.

Latest appointments

  • CureVac’s CEO appointed to EC High Level Group CureVac’s CEO appointed to EC High Level Group

    Dr Hoerr said: “It is a tremendous honor to be selected by the European Commission as member of the High Level Group focused on advancing innovation throughout the European Union. ... Governing board member of the European Institute for Innovation and

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    Lisa will play a leading role as we negotiate the future of our industry outside the European Union and as we work with government to build an industrial strategy with

  • EMVO appoints general manager EMVO appoints general manager

    Andreas Walter brings experience from the EFPIA. The European Medicines Verification Organisation (EMVO) has appointed Andreas Walter as its general manager. ... It was established last year by industry organisations, including EFPIA, and the European

  • Sonia Ruiz Moran appointed president of EMVO Sonia Ruiz Moran appointed president of EMVO

    The European Medicines Verification Organisation (EMVO) has appointed Sonia Ruiz Moran as its new president, replacing John Chave, former secretary general of Pharmaceutical Group of the European Union (PGEU). ... She said: “The planning and design of

  • IMI picks Ipsen's Marc de Garidel to chair governing board IMI picks Ipsen's Marc de Garidel to chair governing board

    De Garidel has been chairman and CEO of Ipsen, which specialises in neurology, endocrinology and urology-oncology, since 2010 and he chaired the European Biopharmaceutical Enterprises Association from 2010-12. ... The IMI is a public-private partnership

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • The future of nanomedicine regulation The future of nanomedicine regulation

    Greater clarity around nanomedicines in the revised pharmaceutical legislation should not only be regarded as a necessary next step to ensure patient safety and promote innovation by the European Union, but ... The European Union has the chance to set a

  • Welcome to the era of the orphan drug Welcome to the era of the orphan drug

    However, the passing of the Orphan Drug Act by the FDA in 1983 and the reciprocal Orphan Drug Regulation by the European Union in 1999 has helped to incentivise drug development

  • GLOBALHealthPR® Welcomes Exclusive France Partner Agency

    France is the second largest economy in the European Union and one of the largest consumers of pharmaceutical products in the world. ... As a member of the network, PRPA will work collaboratively alongside London-based European hub partner Aurora

  • What is everyone ‘ARPAing on about?

    On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and

  • Digital Therapeutics Landscape in Europe Digital Therapeutics Landscape in Europe

    HIGHLIGHTS INCLUDE:. Opportunities and threats of digital therapeutics after COVID-19. Digital therapeutics landscape in the European Union.

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....